Roche tries another challenge to Amgen's anemia drugs
3:30 PM Mon, Feb 04, 2008 | Permalink | Write aLast October, a federal judge in Boston handed Amgen Inc. a major victory, finding that rival drugmaker Roche Holding AG had violated Amgen's patents in designing an anemia drug to compete with Amgen's top-selling medications, Epogen and Aranesp. But now,......
